Effects of Omega-3 Supplementation on Inflammation and Recovery in Sports: A Meta-Analysis
Li Z, Zhang B
FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 0 citas
Cómo se estudió
- Diseño
- Metaanálisis (indexado por PubMed)
- Estudiado en
- Personas
- Resultado principal
- Marcadores de salud y funcionamiento
Quién lo pagó
- Financiación
- Financiación independiente
- Sin clasificar
- No funding
Según 1 financiador declarado.
Publicación
- Publicado
- 2026-03-27 · FASEB J · vol. 40 · número 7 · pág. e71709
- Editorial
- Wiley
- Citado
- 2 citas · más que el 97% de estudios similares · 8.5× el promedio de su campo
- Impacto
- Entre el 10 % más citado de su campo
- Referencias
- 29 trabajos
- Acceso
- De pago
- Áreas de investigación
- Fatty Acid Research and Health · Exercise and Physiological Responses · Muscle metabolism and nutrition
- Palabras clave
- omega-3 fatty acids, eicosapentaenoic acid, docosahexaenoic acid, exercise-induced inflammation, muscle recovery, delayed onset muscle soreness, creatine kinase, interleukin-6, TNF-α, C-reactive protein, nuclear factor-kappaB, specialized pro-resolving mediators, antioxidant capacity, recreational athletes, dietary supplementation
- MeSH
- humans, inflammation, fatty acids, omega-3, docosahexaenoic acids, eicosapentaenoic acid, exercise, sports, dietary supplements, post-exercise recovery, post-exercise recovery techniques
2 autores
- Zhenxing Li🇨🇳Guangdong Justice Police Vocational College
- Bing Zhang🇨🇳 · autor de correspondenciaHuanggang Normal University
Resumen
El texto original del estudio, en el idioma en que se publicó.
Omega-3 polyunsaturated fatty acids (PUFAs) are known to modulate inflammatory signaling and enhance muscle recovery from exercise-induced stress. In this work, a meta-analysis was conducted that adhered to the PRISMA 2020 criteria, incorporating evidence from 41 randomized controlled trials on eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) supplementation, all of which had been conducted as evidence between 2011 and 2025 and evaluated the effects of EPA and DHA supplementation on the primary markers of the impact of exercise on inflammation and muscle injury, including the random-effects model with moderator dose, intervention duration, sex, and training status. The integrated findings showed that interleukin-6, tumor necrosis factor-α, creatine kinase, and delayed-onset muscle soreness (standardized mean difference = -0.4 to -0.7) were significantly and moderately reduced, indicating a uniform response to omega-3 supplementation's anti-inflammatory and recovery-promoting effects. C-reactive protein responses were more dispersed, suggesting that baseline inflammation differed and that the sampling protocols did as well. Subgroup analyses showed that doses of 2 g/day or more of mixed EPA + DHA, with a minimum duration of 6 weeks of administration, produced the strongest effects, especially among recreational athletes rather than elite athletes. Mechanistically, nuclear factor-kappa B activation and the ensuing synthesis of specialized pro-resolving mediators (resolvins, protectins, and maresins), as well as an increase in cellular antioxidant capacity, appear to be moderated by omega-3 supplementation and support efficient resolution of inflammation and tissue repair. These results form a body of evidence over more than 10 years, showing that omega-3 fatty acids are a strong, evidence-based nutritional tool for reducing the effects of post-exercise inflammation, supporting functional recovery, and sustaining long-term athletic performance.
Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial.
Confianza de la comunidad
Cargando…
¿Cuánto confías en los hallazgos de este estudio?
Comentarios
¿Algo está mal aquí?
Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.
Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.